Lederer & Associates Investment Counsel’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,917
| Closed | -$1.45M | – | 83 |
|
2024
Q4 | $1.45M | Sell |
3,917
-171
| -4% | -$63.1K | 1.01% | 35 |
|
2024
Q3 | $2.13M | Sell |
4,088
-10
| -0.2% | -$5.2K | 1.5% | 19 |
|
2024
Q2 | $2.22M | Sell |
4,098
-204
| -5% | -$111K | 1.61% | 14 |
|
2024
Q1 | $2.23M | Sell |
4,302
-8
| -0.2% | -$4.15K | 1.55% | 16 |
|
2023
Q4 | $2.03M | Sell |
4,310
-49
| -1% | -$23.1K | 1.5% | 19 |
|
2023
Q3 | $1.9M | Sell |
4,359
-12
| -0.3% | -$5.23K | 1.51% | 20 |
|
2023
Q2 | $1.94M | Sell |
4,371
-39
| -0.9% | -$17.3K | 1.47% | 22 |
|
2023
Q1 | $2.03M | Buy |
4,410
+306
| +7% | +$141K | 1.56% | 20 |
|
2022
Q4 | $2.11M | Sell |
4,104
-98
| -2% | -$50.3K | 1.72% | 19 |
|
2022
Q3 | $1.91M | Buy |
4,202
+41
| +1% | +$18.6K | 1.61% | 20 |
|
2022
Q2 | $2.01M | Sell |
4,161
-1,230
| -23% | -$594K | 1.55% | 19 |
|
2022
Q1 | $2.65M | Sell |
5,391
-198
| -4% | -$97.3K | 1.62% | 19 |
|
2021
Q4 | $2.59M | Sell |
5,589
-161
| -3% | -$74.6K | 1.5% | 22 |
|
2021
Q3 | $2.14M | Sell |
5,750
-9
| -0.2% | -$3.36K | 1.38% | 27 |
|
2021
Q2 | $2.2M | Buy |
5,759
+244
| +4% | +$93.2K | 1.46% | 26 |
|
2021
Q1 | $1.98M | Sell |
5,515
-183
| -3% | -$65.7K | 1.4% | 26 |
|
2020
Q4 | $1.83M | Sell |
5,698
-663
| -10% | -$213K | 1.4% | 27 |
|
2020
Q3 | $1.71M | Sell |
6,361
-118
| -2% | -$31.7K | 1.42% | 29 |
|
2020
Q2 | $1.7M | Sell |
6,479
-10
| -0.2% | -$2.63K | 1.59% | 25 |
|
2020
Q1 | $1.47M | Buy |
6,489
+759
| +13% | +$172K | 1.67% | 22 |
|
2019
Q4 | $1.73M | Buy |
5,730
+235
| +4% | +$71K | 1.5% | 30 |
|
2019
Q3 | $1.32M | Buy |
5,495
+205
| +4% | +$49.2K | 1.26% | 35 |
|
2019
Q2 | $1.49M | Buy |
5,290
+180
| +4% | +$50.8K | 1.37% | 35 |
|
2019
Q1 | $1.47M | Buy |
+5,110
| New | +$1.47M | 1.36% | 36 |
|